
Medical oncologist and clinical researcher focused on Genitourinary oncology at @hsiriolibanes
Sao Paulo, Brazil
Joined June 2018
- Tweets142
- Following336
- Followers669
- Likes495
Happy to share the results of our randomized phase II of intense ADT prior to prostatectomy for high-risk prostate cancer, including PSMA/PET correlation with path outcomes! @DrRanaMcKay @Silke_Gillessen @SoaresAndrey @RafaelFCoelho2 @montypal @g_develasco @DRathkopf
Interesting review on promising novel AR directed therapies for advanced prostate cancer. Several new and different potential approaches to tackle the AR pathway. Thanks @EAntonarakis and Pedro Isaacson! @jardim_denis @SoaresAndrey @FabioSchutz78
Thanks for participating !! Hope we will be able to have these great discussions in person!!
Replying to @montypal @DiogoAssed @LacogG @PauloBergerot @crisbergerot @manuelmaiamd @DrAndreFay @PGrivasMDPhD @VivekSubbiah @DrChoueiri @FaltasLab @neerajaiims
We’re very happy Monty! Anxious to see your talk. Hope to see you in Brazil ASAP.
2
Oncology Clinical Trials During the COVID-19 Pandemic cancernetwork.com/view/oncol… via @CancerNetwrk
1
14
Rubraca® (Rucaparib) Approved in the U.S. as Monotherapy Treatment for Patients with BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Business Wire businesswire.com/news/home/2…
What has been your institutional guidelines regarding Covid19 PCR testing for asymptomatic patients prior to oncologic treatments (chemotherapy / immunotherapy)? @montypal @neerajaiims @FabioSchutz78 @apolo_andrea @DrChoueiri @ERPlimackMD @GlopesMd @BourlonMaite @Silke_Gillessen
25%All patients (chemo / IO)
4%Only prior to chemo
9%Only heme malignancies
62%No tests unless symptoms
168 votes • Final results





